Training and Research in Colon Cancer Survival

结肠癌生存培训和研究

• 批准号: 9751785
• 负责人: POLLY A NEWCOMB
• 金额: $ 8.9万
• 依托单位: FRED HUTCHINSON CANCER RESEARCH CENTER
• 依托单位国家: 美国
• 财政年份: 2015
• 资助国家: 美国
• 起止时间: 2015-09-01 至 2021-12-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9751785
• 关键词: Age; Area; Award; BRAF gene; Behavioral Genetics; Biology; Cancer Control; Cancer Etiology; Cancer Survivor; Cancer Survivorship; Caregivers; Cessation of life; Characteristics; Clinical Research; Collaborations; Colon Carcinoma; Colonic Neoplasms; Colorectal Cancer; Colorectal Neoplasms; Complex; CpG Island Methylator Phenotype; Data; Developed Countries; Developing Countries; Development; Diagnosis; Disease; Epidemiologic Factors; Epidemiology; Europe; Funding; Future; Generations; Genetic; Genetic Variation; Goals; Grant; Growth; Individual; International; Joints; KRAS2 gene; Knowledge; Longevity; Malignant Neoplasms; Manuscripts; Mentors; Mentorship; Methods; Microsatellite Instability; Molecular; Mutation; North America; Obesity; Observational Study; Outcome; Participant; Patients; Population; Postdoctoral Fellow; Preparation; Prevention Research; Principal Investigator; Production; Recording of previous events; Reporting; Research; Research Personnel; Research Project Grants; Research Support; Resources; Risk Factors; Sample Size; Scientist; Senior Scientist Award; Smoking; Survival Analysis; Testing; Training; Training Support; Tumor Markers; United States; United States National Institutes of Health; Universities; Validation; Washington; Woman; Work; Writing; cancer diagnosis; cancer epidemiology; cancer genome; cancer prevention; cancer survival; career; cohort; colon cancer family registry; colon cancer patients; data registry; design; experience; follow-up; genetic epidemiology; genetic variant; improved; insight; men; molecular subtypes; mortality; pre-doctoral; predictive modeling; public health relevance; responsible research conduct; screening; sex; skills; study population; success; tumor

 DESCRIPTION (provided by applicant): This is a renewal of an Established Investigator award for Dr. Polly Newcomb to dedicate 30% effort to training and research in colorectal cancer survivorship. She is an experienced cancer prevention and control investigator with a long and successful record of continuous NIH-funding, with nearly $40 M in direct awards to her as Principal Investigator. An effective mentor, she has worked with over 40 young scientists on their way to independent careers in cancer prevention and control. This K05 has allowed her to focus her career on the epidemiology and genetics of colon cancer survival. With support of the K05 she has obtained additional skills, had 4 R01 proposals funded as PI, and worked with 24 outstanding junior investigators to author ~70 study reports focused on cancer survivorship. The epidemiology of cancer survival continues to be an essential area, as the population of cancer survivors is rapidly growing because of screening and treatment successes; today more than 14 million U.S. individuals have a history of cancer. Therefore, identifying approaches to improve survival in colorectal cancer patients is a high priority for patients, clinicians, and caregivers. Colorectal cancer is a complex disease caused by the joint action of environmental, behavioral, and genetic factors; longevity after diagnosis too must reflect these joint effects. The research goals of this K05 awards are to: 1) Further develop and actively participate in the newly emerging International Survival Analysis of Colorectal Cancer Consortium (ISACC) that currently includes 23 studies and nearly 27,000 colorectal cancers, in order to initiate research projects with Consortium investigators and mentees to leverage the diverse and well-annotated populations and biospecimens collected by the participating studies; 2) Test whether the colon tumor genome, as defined by BRAF mutation, KRAS mutation, CpG Island Methylator Phenotype (CIMP), and microsatellite instability (MSI) status, is associated with colorectal cancer survival, and assess whether this association is modified by epidemiologic factors or common germline genetic variants; and 3) Develop and validate a prognostic model for survival utilizing the tumor genome, epidemiologic factors, and germline genetic variants. Cancer survivorship is a challenging area of prevention research with unique methods for analyses and controlling bias, making mentorship of junior investigators key to the successful production of significant and impactful research results. There is an outstanding pool of pre- and post-doctoral trainees from the University of Washington, with mentee funding available from 4 training grants with which Dr. Newcomb serves as a mentor and/or on the Executive Committee. Dr. Newcomb regularly meets with trainees individually, and weekly as a group, to develop expertise in study conduct, analyses, manuscript preparation, grant writing, and the responsible conduct of research. The renewal of the K05 award will be an invaluable mechanism to better understand the factors that can enhance cancer survival, and in doing so, develop junior researchers highly skilled in cancer control.

 描述（由申请人提供）：这是对Polly纽科姆博士的既定研究者奖的延续，以将30%的精力投入到结直肠癌生存的培训和研究中。她是一位经验丰富的癌症预防和控制研究人员，长期以来一直成功地获得NIH的资助，作为首席研究员，她获得了近4000万美元的直接奖励。作为一名有效的导师，她曾与40多名年轻科学家一起工作，帮助他们独立从事癌症预防和控制工作。这个K 05使她能够专注于结肠癌生存的流行病学和遗传学。在K 05的支持下，她获得了额外的技能，作为PI资助了4项R 01提案，并与24名优秀的初级研究者合作，撰写了约70份专注于癌症生存率的研究报告。癌症生存的流行病学仍然是一个重要的领域，因为癌症幸存者的人口正在迅速增长，因为筛查和治疗的成功;今天超过1400万美国人有癌症史。因此，确定提高结直肠癌患者生存率的方法是患者，临床医生和护理人员的高度优先事项。 结直肠癌是一种由环境、行为和遗传因素共同作用引起的复杂疾病;诊断后的寿命也必须反映这些联合作用。本次K 05奖的研究目标是：1）进一步发展并积极参与新出现的国际结直肠癌生存分析联盟（ISACC），该联盟目前包括23项研究和近27，000例结直肠癌，为了与联盟研究人员和学员一起启动研究项目，以利用多样化和良好的参与研究收集的注释种群和生物标本; 2）测试由BRAF突变、KRAS突变、CpG岛甲基化表型（CIMP）和微卫星不稳定性（MSI）状态定义的结肠肿瘤基因组是否与结直肠癌生存相关，并评估这种关联是否被流行病学因素或常见的生殖系遗传变异所改变;以及3）利用肿瘤基因组、流行病学因素和生殖系遗传变异来开发并验证生存的预后模型。癌症生存率是预防研究的一个具有挑战性的领域，具有独特的分析和控制偏倚的方法，使初级研究人员的指导成为成功产生重大和有影响力的研究结果的关键。华盛顿大学有一批优秀的博士前和博士后学员，学员资金来自4项培训赠款，纽科姆博士担任导师和/或执行委员会成员。纽科姆博士定期与学员单独会面，每周一次作为一个小组，以发展在研究进行，分析，手稿准备，赠款写作和负责任的研究行为方面的专业知识。K 05奖的更新将是一个非常宝贵的机制，可以更好地了解可以提高癌症生存率的因素，并在此过程中培养在癌症控制方面具有高度技能的初级研究人员。

项目成果

Reply to F. Tomao et al.

回复 F. Tomao 等人。

• DOI: 10.1200/jco.18.02063
• 发表时间: 2019
• 期刊: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
• 作者: Hensley,MarteeL;Enserro,Danielle;Miller,DavidS
• 通讯作者: Miller,DavidS

Oral bisphosphonate use and colorectal cancer incidence in the Women's Health Initiative.

• DOI: 10.1002/jbmr.1930
• 发表时间: 2013-09
• 期刊: JOURNAL OF BONE AND MINERAL RESEARCH
• 影响因子: 6.2
• 作者: Passarelli, Michael N.;Newcomb, Polly A.;LaCroix, Andrea Z.;Lane, Dorothy S.;Ho, Gloria Y. F.;Chlebowski, Rowan T.
• 通讯作者: Chlebowski, Rowan T.